Brooklyn, NY, United States of America

Christine Berglund

This inventor holds 24 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Capital One Services, LLC, Government Employees Insurance Company (Geico). Active years: 2019-2026.

USPTO Granted Patents = 24 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christine Berglund

Introduction: Christine Berglund, a pioneering inventor hailing from Brooklyn, NY, has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Christine Berglund holds several patents in various fields, including technology, healthcare, and sustainable energy. Her most recent patent is a revolutionary medical device designed to improve patient care and outcomes.

Career Highlights: Throughout her illustrious career, Christine Berglund has been recognized for her inventive spirit and problem-solving skills. She has received numerous awards for her innovative contributions to society and has been a keynote speaker at prestigious innovation conferences worldwide.

Collaborations: Christine Berglund has collaborated with leading research institutions, universities, and companies to bring her ideas to life. Her partnerships have led to the development of cutting-edge technologies that have had a lasting impact on industries ranging from biotech to artificial intelligence.

Conclusion: In conclusion, Christine Berglund's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of inventors. Her dedication to creating solutions that address real-world challenges continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…